Alkem Labs dips after observations from UK-MHRA

The company said that UK-MHRA has made eight observations following inspection of its Taloja facility

Shares of Alkem Laboratories were down nearly 4% at Rs 1,318 on the Bombay Stock Exchange after observations made by the UK health regulator, UK-Medicines and Healthcare Products Regulatory Agency following an inspection at the company's bioequivalence facility located at Taloja, Maharashtra in March 2016.

The company in a release said that it has received the inspection report from the UK-MHRA dated March 30,2016 where eight observations have been made by the UK-MHRA.

The release added that the company is in the process of putting together responses to address observations made by the UK-MHRA in the report and will submit the reponses within the timeline stipulated by the UK-MHRA.
 

The stock touched a high of Rs 1,328 and a low of Rs 1271. At 10:50am, over 249,000 shares were traded on the stock exchanges.